Skip to main content
Log in

Prescriptions for branded and generic pharmaceuticals

  • Academic Paper
  • Published:
Journal of Brand Management Aims and scope Submit manuscript

Abstract

The paper makes an empirical contribution to the debate on brand value by questioning the concept of intrinsic equity as opposed to market advantage due solely to the size of market share.

While only one specific industry is covered by the research, striking patterns familiar to analysts of consumer markets are found which should make all marketing professionals look for similarities in the markets for which they are responsible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Authors

Additional information

1Philip Stern is Lecturer in Marketing and Strategic Management at Warwick Business School. As well as contributing to the MBA programmes, Dr Stern is actively involved in executive education and has managed the programmes run by Warwick for Nestlé UK for a number of years. He has worked in new product development and production management for Unilever and spent an enlightening period as a European Category Merchandiser for Avon Products.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stern, P. Prescriptions for branded and generic pharmaceuticals. J Brand Manag 2, 177–183 (1994). https://doi.org/10.1057/bm.1994.48

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1057/bm.1994.48

Navigation